These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2211375)

  • 1. Studies on orally active cephalosporin esters. VI. Synthesis and antimicrobial activity of 3-(3-isoxazolyl)oxymethylcephalosporin derivatives.
    Nakayama E; Watanabe K; Miyauchi M; Fujimoto K; Ide J
    J Antibiot (Tokyo); 1990 Sep; 43(9):1122-30. PubMed ID: 2211375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)- (4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound.
    Sakagami K; Atsumi K; Yamamoto Y; Tamura A; Yoshida T; Nishihata K; Fukatsu S
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2433-6. PubMed ID: 1804557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoylamino]-3-cephems with C-3 substitutions.
    Ishikura K; Kubota T; Minami K; Hamashima Y; Nakashimizu H; Motokawa K; Kimura Y; Miwa H; Yoshida T
    J Antibiot (Tokyo); 1994 Apr; 47(4):466-76. PubMed ID: 8195047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. V. Synthesis and antibacterial activity of 7 beta-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin derivates and related compounds.
    Ochiai M; Morimoto A; Miyawaki T; Matsushita Y; Okada T; Natsugari H; Kida M
    J Antibiot (Tokyo); 1981 Feb; 34(2):171-85. PubMed ID: 6271716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2- aminothiazol-4-yl)-3-(substituted)-2-propenoyl-amino]-3- desacetoxymethylcephalosporins.
    Ishikura K; Kubota T; Minami K; Hamashima Y; Nakashimizu H; Motokawa K; Yoshida T
    J Antibiot (Tokyo); 1994 Apr; 47(4):453-65. PubMed ID: 8195046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]-3-(1,2,3-triazol-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds].
    Sakagami K; Sakai M; Kashi T; Ishimaru T
    Yakugaku Zasshi; 1989 Dec; 109(12):957-61. PubMed ID: 2630639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids.
    Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
    J Antibiot (Tokyo); 1993 Feb; 46(2):316-30. PubMed ID: 8468248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on condensed-heterocyclic azolium cephalosporins. V. Synthesis and antibacterial activity of 3-(condensed-triazolo-pyridinium, -pyrimidinium, and -pyridazinium)-methyl cephalosporins.
    Yoshimura Y; Tomimatsu K; Nishimura T; Miyake A; Hashimoto N
    J Antibiot (Tokyo); 1992 May; 45(5):721-34. PubMed ID: 1624374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on orally active cephalosporin esters.
    Fujimoto K; Ishihara S; Yanagisawa H; Ide J; Nakayama E; Nakao H; Sugawara S; Iwata M
    J Antibiot (Tokyo); 1987 Mar; 40(3):370-84. PubMed ID: 3570989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins.
    Yamamoto H; Terasawa T; Ohki A; Shirai F; Kawabata K; Sakane K; Matsumoto S; Matsumoto Y; Tawara S
    Bioorg Med Chem; 2000 Jan; 8(1):43-54. PubMed ID: 10968263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin antibiotics. I. Synthesis and structure-activity relationships of 3-thiazoliomethyl derivatives.
    Nakayama E; Fujimoto K; Muramatsu S; Miyauchi M; Watanabe K; Ide J
    J Antibiot (Tokyo); 1991 Aug; 44(8):854-63. PubMed ID: 1917700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on FK482 (Cefdinir). IV. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]- 3-substituted cephalosporin derivatives].
    Inamoto Y; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Dec; 110(12):908-15. PubMed ID: 2074536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on cephalosporin antibiotics. VI. Synthesis, antibacterial activity and oral efficacy in mice of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)-acetamido]-3- (substituted alkylthio)cephalosporins.
    Yokoo C; Onodera A; Fukushima H; Numata K; Nagate T
    J Antibiot (Tokyo); 1992 Sep; 45(9):1533-9. PubMed ID: 1429240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a new series of cephalosporins having 3-substituted-ammonio-1-propenyl group as the C-3 side chain.
    Kamachi H; Oka M; Narita Y; Iimura S; Aburaki S; Yamashita H; Tomatsu K; Okumura J; Naito T
    J Antibiot (Tokyo); 1990 May; 43(5):533-43. PubMed ID: 2358405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalosporins. VI. Synthesis and structure-activity relationships of new 7 beta-[(Z)-2-alkoxyimino-2-(2-aminothiazol-4-yl)acetamido]cephalosporins with a tetraxolopyridazine at the 3-position.
    Alpegiani M; Casabuona F; Giorgi R; Nannini G; Perrone E; Meinardi G; Bianchi A; Monti G
    J Antibiot (Tokyo); 1983 Aug; 36(8):1013-9. PubMed ID: 6630053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787.
    Miyake A; Yoshimura Y; Yamaoka M; Nishimura T; Hashimoto N; Imada A
    J Antibiot (Tokyo); 1992 May; 45(5):709-20. PubMed ID: 1624373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use.
    Kamachi H; Narita Y; Okita T; Abe Y; Iimura S; Tomatsu K; Yamasaki T; Okumura J; Naito T; Oki T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1602-16. PubMed ID: 3198494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antipseudomonal cephalosporin CP6162 and its congeners.
    Iwamatsu K; Atsumi K; Sakagami K; Ogino H; Yoshida T; Tsuruoka T; Shibahara S; Inouye S; Kondo S
    J Antibiot (Tokyo); 1990 Nov; 43(11):1450-63. PubMed ID: 2125591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on FK482. II. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-substituted acetamido]-3-vinyl-3-cephem-4-carboxylic acid derivatives].
    Inamoto Y; Chiba T; Sakane K; Kamimura T; Takaya T
    Yakugaku Zasshi; 1990 Apr; 110(4):246-57. PubMed ID: 2376819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic cephalosporins. V. Synthesis and antibacterial activity of 3-alkylthio-7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]cephalosporins and related compounds].
    Sakagami K; Watanabe T; Fukatsu S; Nitta H; Hatanaka M; Ishimaru T
    Yakugaku Zasshi; 1989 Dec; 109(12):913-25. PubMed ID: 2698417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.